As older persons may value independence over longevity, these studies should not only evaluate traditional morbidity and mortality but also patient-reported health outcomes, such as health-related quality of life and function, and active life expectancy (e.g., home time) [142]. Such comparative ...
US Food and Drug Administration. While these anticoagulants carry similar side effects to warfarin, such as risk for gastrointestinal bleeding and intracranial hemorrhage, INR and PT monitoring are not required. How then are providers to gauge the safety and efficacy of the medication in a patient?
The model was adjusted for patient characteristics that might explain the association between race/ethnicity and outcomes, including clinical characteristics (eg, medical history, laboratory data, medications, and AF type), clinician type, and sociodemographic characteristics (eg, education, insurance type...
While ongoing education of clinicians is important, this issue can only be reliably overcome by instituting sample collection protocols that consider the withholding of DOACs for an appropriate time frame, if considered safe for any given patient, based on drug and renal clearance. The updated ISTH...
In adults, untreated heparin-induced thrombocytopenia type II (HIT type II) with complicating thrombosis has been associated with the death of the patient in up to 28% of cases [4]. For this reason in adults, prompt cessation of heparin and continuance of anticoagulation with Org 10172 (danapa...
Platelet function tests are capable of detecting and/or ruling out the presence of a platelet inhibitor. The intensity of platelet inhibition can be assessed, allowing an estimation of the bleeding risk. This might be useful especially when the patient’s medication is unknown. ...
Predictors of anticoagulant treatment in patients with nonvalvular atrial fibrillation_ results from atrial fibrillation in Turkey_ epidemiologic registry.pdf 2015-03-21上传 暂无简介 文档格式: .pdf 文档大小: 153.6K 文档页数: 5页 顶/踩数:
Treatment with a low dose of human plasma-derived FVIII (0.05 IU per mouse, IV, equivalent to the FVIII level in severe hemophilia A patient) 30 minutes prior to the tail clip partially reduced the bleeding time of PROC+/+;F8−/− mice. Significantly, pretreatment with HAPC1573 (20 ...
Patients’ satisfaction determines the adherence to their treatment; thus, the therapy outcome is improved [62]. Thus, many of the mentioned medication errors could be prevented if health professionals would become more involved in patient education and satisfaction [63,64]. The collaboration and the...